GlobalData on MSN

Pharma R&D set to endure despite rising MFN costs

The US bears the highest drug costs globally, a dynamic that helps fund pharma R&D and benefits patients worldwide. As ...

NEW BOOK, examines pharmaceutical policy in Canada and its impact on patients, taxpayers, innovation, and trade relations with the United States

Does Canada pay a fair share of the global cost of pharmaceutical innovation? Are the prices for patented medicines threatening the sustainability of public drug plans? How many new drugs are covered ...
Forbes

Optimizing R&D In Pharma: R&D Operations Ecosystem Powered By Cloud Computing

The pharmaceutical industry has immense pressure to deliver advanced and novel therapies to patients worldwide but faces monumental challenges in drug development. On average, the journey from ...
STATOpinion

Pharma’s shift away from infectious disease research could spell disaster for the world’s poorest people

The number of “innovation champions” in the pharma industry working on infectious diseases is dropping — and that’s troubling ...
Finanznachrichten

Black Book Research: Pharma Executives Redefine IT Priorities: Five Stats Signal Urgent Tech Shift

Black Book Research Q2-Q3 proprietary surveys reveal digital health, cybersecurity, and data platforms as the foundation of pharma's future competitiveness PHILADELPHIA, PA / ACCESS Newswire / ...

Centre proposes Rs 5,000 crore R&D booster for Pharma and MedTech: Can it drive innovation?

The initiative, backed by a total financial outlay of Rs 5,000 Crore (nearly $600 million) spanning from FY 2023-24 to FY ...
Hosted on MSN

Bayer exec: Trump pharma tariffs would negatively impact R&D

If President Trump's threat to impose tariffs on pharmaceutical products goes through, it would have severe consequences for industry R&D efforts, according to a Bayer (OTCPK:BAYZF) pharma executive. ...